PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
September 21, 2024Cancer Epidemiology Biomarkers & Prevention

Abstract C149: Relationship between PD-L1 expression and clinicopathological characteristics in Hispanic/ Latino women with breast cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

DMDaniel Mendivelso-GonzálezPCPatricia López- CorreaNPNicolás Prada-Aceros

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mendivelso-González et al. (2024) studied this question.

synapsesocial.com/papers/68e57c1db6db64358751b3c4https://doi.org/10.1158/1538-7755.disp24-c149
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Programmed Death-Ligand 1 Expression in Triple-Negative Breast Cancer: Insights from a Mexican Cohort2026 · 1 citations
  2. 2Association of <scp>PD‐L1</scp> expression with driver gene mutations and clinicopathological characteristics in non‐small cell lung cancer: A real‐world study of 10 441 patients2024 · 6 citations
  3. 3Abstract PS2-12-05: Programmed death-ligand 1expression in triple negative breast cancer: insights from an African ancestry-enriched multinational cohort2026
  4. 4Abstract PO5-16-07: Unveiling the Landscape of PD-L1 Expression and Tumor-Infiltrating Lymphocyte Subtypes in Advanced Triple-Negative Breast Cancer2024
  5. 5Abstract 4977: Programmed cell death ligand 1 (PD-L1) expression across molecular subtypes of human high-grade ductal carcinoma in situ (DCIS) of the breast2026